羅哌卡因復(fù)合舒芬太尼用于剖宮產(chǎn)麻醉的臨床效果探討

張孝寶

【摘 要】目的：探討羅哌卡因復(fù)合舒芬太尼用于剖宮產(chǎn)麻醉的臨床效果。方法：選取本院于2020年1月至2021年1月間收治的84例剖宮產(chǎn)產(chǎn)婦為研究對(duì)象，采用隨機(jī)抽簽的方式進(jìn)行分組，分為實(shí)驗(yàn)組和對(duì)照組，每組各42例，對(duì)照組采用羅哌卡因治療，實(shí)驗(yàn)組采用羅哌卡因復(fù)合舒芬太尼治療。結(jié)果：在鎮(zhèn)痛維持時(shí)間、麻醉起效時(shí)間、術(shù)后疼痛程度方面，在MAP、DBP、SBP、SpO2方面，在不良反應(yīng)發(fā)生率方面，實(shí)驗(yàn)組和對(duì)照組各項(xiàng)結(jié)果的數(shù)據(jù)差異均具有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論：在剖宮產(chǎn)麻醉中應(yīng)用羅哌卡因復(fù)合舒芬太尼，能夠有效保持產(chǎn)婦的血流動(dòng)力學(xué)水平的穩(wěn)定，減少產(chǎn)婦的術(shù)后疼痛，降低不良反應(yīng)發(fā)生率，提高產(chǎn)婦的術(shù)后恢復(fù)，值得臨床推廣和使用。

【關(guān)鍵詞】羅哌卡因；舒芬太尼；剖宮產(chǎn)麻醉

The clinical effect of ropivacaine combined with sufentanil in anesthesia for cesarean section

Zhang Xiaobao

Central Hospital of Shagou Town， YishuiCounty，Shandong， Linyi Shandong 276400， China

【Abstract】Objective：To explore the clinical effect of ropivacaine combined with sufentanil in anesthesia for cesarean section. Methods： A total of 84 cases of cesarean section women admitted to our hospital between January 2020 and January 2021 were selected as the research subjects. They were divided into experimental group and control group by random drawing， with 42 cases in each group. The control group was treated with ropivacaine， and the experimental group was treated with ropivacaine combined with sufentanil. Results： In terms of analgesia maintenance time， anesthesia onset time， postoperative pain degree， in terms of MAP， DBP， SBP， SpO2， and in terms of the incidence of adverse reactions， the data differences between the experimental group and the control group were statistically significant（P<0.05）.Conclusion：The application of ropivacaine combined with sufentanil in cesarean section anesthesia can effectively maintain the stability of maternal hemodynamics， reduce maternalpostoperative pain， reduce the incidence of adverse reactions， and improve maternal postoperative recovery，It is worthy of clinical promotion and use.

【Key？Words】Ropivacaine； Sufentanil； Cesarean section anesthesia

產(chǎn)婦分娩的重要方式之一，就是剖宮產(chǎn)。對(duì)于部分難產(chǎn)的產(chǎn)婦和妊娠期出現(xiàn)并發(fā)癥的產(chǎn)婦而言，剖宮產(chǎn)是較為常用的分娩方式，能夠有效地保障胎兒和產(chǎn)婦的生命安全。近年來(lái)，隨著我國(guó)醫(yī)療技術(shù)突飛猛進(jìn)的發(fā)展，以及人們思想意識(shí)的變化，我國(guó)選擇剖宮產(chǎn)的產(chǎn)婦越來(lái)越多[1]。在剖宮產(chǎn)的手術(shù)過(guò)程中，麻醉是確保母嬰安全、剖產(chǎn)手術(shù)順利開(kāi)展的重要保障，因此，對(duì)于麻醉的方式、麻醉藥物的選擇需要合理、科學(xué)、符合產(chǎn)婦的實(shí)際情況[2]。本文通過(guò)探討羅哌卡因復(fù)合舒芬太尼用于剖宮產(chǎn)麻醉的臨床效果，分析其臨床價(jià)值，具體內(nèi)容如下。

1.1 基線資料

選取本院于2020年1月至2021年1月間收治的84例剖宮產(chǎn)產(chǎn)婦為研究對(duì)象，采用隨機(jī)抽簽的方式進(jìn)行分組，分為實(shí)驗(yàn)組和對(duì)照組，每組42例。……